Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009.

Craig BM, Brisson M, Chesson H, Giuliano AR, Jit M.

Clin Ther. 2010 Aug;32(8):1546-64. doi: 10.1016/j.clinthera.2010.06.017.

2.

Rome Consensus Conference - statement; human papilloma virus diseases in males.

Lenzi A, Mirone V, Gentile V, Bartoletti R, Ficarra V, Foresta C, Mariani L, Mazzoli S, Parisi SG, Perino A, Picardo M, Zotti CM.

BMC Public Health. 2013 Feb 7;13:117. doi: 10.1186/1471-2458-13-117.

4.

Implementation of human papillomavirus immunization in the developing world.

Kane MA, Serrano B, de Sanjosé S, Wittet S.

Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Review.

PMID:
23199963
5.

Anti-HPV vaccination: a review of recent economic data for Italy.

Mennini FS, Costa S, Favato G, Picardo M.

Vaccine. 2009 May 29;27 Suppl 1:A54-61. doi: 10.1016/j.vaccine.2009.02.052. Review.

PMID:
19480963
6.

Economic evaluation of human papillomavirus vaccination in developed countries.

Brisson M, Van de Velde N, Boily MC.

Public Health Genomics. 2009;12(5-6):343-51. doi: 10.1159/000214924. Review.

PMID:
19684446
7.

Human papillomavirus quadrivalent vaccine: a look behind the numbers.

Flaherty DK, Alkhateeb FM.

Ann Pharmacother. 2009 Apr;43(4):740-4. doi: 10.1345/aph.1L483. Review.

PMID:
19276314
8.

Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.

Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller JT, Garnett GP, Meheus A.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/251-61. Review.

PMID:
16950014
9.

Virus-like particles for the prevention of human papillomavirus-associated malignancies.

Wang JW, Roden RB.

Expert Rev Vaccines. 2013 Feb;12(2):129-41. doi: 10.1586/erv.12.151. Review.

10.
11.

Safety of human papillomavirus vaccines: a review.

Stillo M, Carrillo Santisteve P, Lopalco PL.

Expert Opin Drug Saf. 2015 May;14(5):697-712. doi: 10.1517/14740338.2015.1013532. Review.

12.

Indications for the HPV vaccine in adolescents: a review of the literature.

Soares GR, Vieira Rda R, Pellizzer EP, Miyahara GI.

J Infect Public Health. 2015 Mar-Apr;8(2):105-16. doi: 10.1016/j.jiph.2014.08.011. Review.

PMID:
25453595
13.

Population impact of HPV vaccines: summary of early evidence.

Hariri S, Markowitz LE, Dunne EF, Unger ER.

J Adolesc Health. 2013 Dec;53(6):679-82. doi: 10.1016/j.jadohealth.2013.09.018. Review.

PMID:
24263069
14.

Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.

Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA.

Vaccine. 2013 Dec 29;31 Suppl 5:F47-52. doi: 10.1016/j.vaccine.2012.06.066. Review.

PMID:
24331747
15.

Introduction of human papillomavirus vaccination in Nordic countries.

Sander BB, Rebolj M, Valentiner-Branth P, Lynge E.

Vaccine. 2012 Feb 14;30(8):1425-33. doi: 10.1016/j.vaccine.2011.11.097. Review.

PMID:
22154773
16.

Human papillomavirus vaccine introduction--the first five years.

Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JM.

Vaccine. 2012 Nov 20;30 Suppl 5:F139-48. doi: 10.1016/j.vaccine.2012.05.039. Review. Erratum in: Vaccine. 2014 Feb 26;32(10):1225.

PMID:
23199957
17.

Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.

Bosch FX, Tsu V, Vorsters A, Van Damme P, Kane MA.

Vaccine. 2012 Nov 20;30 Suppl 5:F1-11. doi: 10.1016/j.vaccine.2012.05.090. Review.

PMID:
23199951
18.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.

Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS, Rogovskaya SI, Arbyn M, Syrjänen S.

Vaccine. 2013 Dec 31;31 Suppl 7:H59-70. doi: 10.1016/j.vaccine.2013.03.029. Review.

PMID:
24332298
19.

HPV and cervical cancer: screening or vaccination?

Bosch FX, Castellsagué X, de Sanjosé S.

Br J Cancer. 2008 Jan 15;98(1):15-21. doi: 10.1038/sj.bjc.6604146. Review.

20.

Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.

Koulova A, Tsui J, Irwin K, Van Damme P, Biellik R, Aguado MT.

Vaccine. 2008 Dec 2;26(51):6529-41. doi: 10.1016/j.vaccine.2008.08.067. Review.

PMID:
18805453
Items per page

Supplemental Content

Support Center